Product Name | MF | CAS | Details |
---|
5,6-Dichloro-1-ethyl-3-sulfobutyl-2-(3-(5,6-dichloro-1-ethyl-3-sulfobutylbenzimidazolinylidene-1-propenyl)benzimidazolium hydroxide, inner salt, sodium salt | C29H35Cl4N4NaO6S2 | 18462-64-1 | Details |
H-EGSRNQDWL-OH | Details |
BMS 929075 | C31H24F2N4O3 | 1217338-97-0 | Details |
Ethyl 2,2-difluoro-2-(pyridin-3-yl)acetate | C9H9F2NO2 | 1247716-64-8 | Details |
Ankyrin 1 antibody | Details |
LRRC8D antibody | Details |
2-Amino-N-(2-chloro-4-fluorophenyl)benzamide | C13H10ClFN2O | 926225-35-6 | Details |
2-(Bromomethyl)-4-methoxy-1-nitrobenzene | C8H8BrNO3 | 67567-46-8 | Details |
5-[(3-Methoxyphenyl)methyl]-1,3,4-oxadiazole-2-thiol | C10H10N2O2S | 1038368-50-1 | Details |
Methyl 2-methyl-4H-pyrrolo[3,2-d][1,3]thiazole-5-carboxylate | C8H8N2O2S | 238749-56-9 | Details |
(R)-2-Methylmorpholine | C5H11NO | 790184-33-7 | Details |
Monoethyl Pimelate | C9H16O4 | 33018-91-6 | Details |
1-Bromo-2-cyclopropoxybenzene | C9H9BrO | 38380-86-8 | Details |
LY24522473 | C22H22N4O2 | 1029692-15-6 | Details |
2-Amino-6-methoxybenzene-1-sulfonamide | C7H10N2O3S | 393089-40-2 | Details |
Caerulein (desulfated) | C58H73N13O18S | 20994-83-6 | Details |
3-(Methanesulfinylmethyl)-1-benzothiophene-2-carboxylic acid | C11H10O3S2 | 1247628-27-8 | Details |
Ibrutinib-MPEA | C32H39N9O2 | 1710768-30-1 | Details |
1-(3,5-Dimethylpiperidine-1-carbonyl)-3-methyl-1H-imidazol-3-ium iodide | C12H20N3O+.I- | 1231954-03-2 | Details |
N-Ethyloxan-3-amine hydrochloride | C7H16ClNO | 1909336-99-7 | Details |
Cupric acetate | C2H4O2.1/2Cu | 142-71-2 | Details |
Iodobenzene 1,1-diacetate | C10H11IO4 | 3240-34-4 | Details |
Pantoprazole impurity | C24H24F2N4O5S | 957470-58-5 | Details |
Kcc2 blocker 1 | C22H25NO5S | 1228439-36-8 | Details |
7-Methoxy-1-methyl-1H-indazole-5-carboxylic acid | C10H10N2O3 | 1373223-79-0 | Details |
{4-[(2-Ethyl-1H-imidazol-1-yl)methyl]phenyl}methanamine | C13H17N3 | 1018053-76-3 | Details |
(2S)-2-Amino-N-methyl-4-(methylsulfanyl)butanamide hydrochloride | C6H15ClN2OS | 94847-37-7 | Details |
Bombinakinin-GAP | C145H219N39O39S3 | 573671-91-7 | Details |
6-Bromo-2,3-dihydrobenzofuran | C8H7BrO | 189035-22-1 | Details |
2-Azido-2-deoxy-3,4-O-isopropylidene-L-gulonic acid methyl ester | Details |
3-Amino-6-chloropyridazine | C4H4ClN3 | 5469-69-2 | Details |
4-Methylpyrimidine-2-carbaldehyde | C6H6N2O | 933745-52-9 | Details |
7-Bromo-2-chlorothieno[3,2-d]pyrimidine | C6H2BrClN2S | 1152475-42-7 | Details |
tert-butyl 4-(5-amino-4H-1,2,4-triazol-3-yl)piperazine-1-carboxylate | C11H20N6O2 | 1263286-45-8 | Details |
3-(3,5-Dimethoxyphenyl)-3-fluoropyrrolidine hydrochloride | C12H17ClFNO2 | 1803604-39-8 | Details |
4-Bromobenzo[b]thiophene | C8H5BrS | 5118-13-8 | Details |
3'-Methylacetophenone | C9H10O | 585-74-0 | Details |
TP53INP2 Blocking Peptide | Details |
anti-Chicken IgY Fc Antibody | Details |
Clindamycin-B2-phosphate | C17H32ClN2O8PS | 54887-31-9 | Details |
Cabazitaxel | C45H57NO14 | 183133-96-2 | Details |
BI 9564 | C20H23N3O3 | 1883429-22-8 | Details |
Veratramide | C9H11NO3 | 1521-41-1 | Details |
Glycoprotein Ib antibody | Details |
Thioacetic acid | C2H4OS | 507-09-5 | Details |
2-Chloro-5-phenyloxazole | C9H6ClNO | 62124-43-0 | Details |
(S)-2-(Tetrahydrofuran-3-yl)acetic acid | C6H10O3 | 146255-26-7 | Details |
SNRK antibody | Details |
1-(7-amino-3,4-dihydroquinolin-1(2H)-yl)ethanone | C11H14N2O | 545394-33-0 | Details |
tert-Butyl 4-(2-chloroacetamido)piperidine-1-carboxylate | C12H21ClN2O3 | 865432-01-5 | Details |
3-Bromo-5-fluoro-2-nitropyridine | C5H2BrFN2O2 | 1258544-91-0 | Details |
Methyl (2S)-2-aminohex-5-ynoate hydrochloride | C7H12ClNO2 | 1379445-19-8 | Details |
Z-NH-PEG2-CH2COOH | C14H19NO6 | 165454-06-8 | Details |
Nintedanib | C31H33N5O4 | 656247-17-5 | Details |
Indacaterol maleate | C24H28N2O3.C4H4O4 | 753498-25-8 | Details |
GSK 503 | C31H38N6O2 | 1346572-63-1 | Details |
1-Butyl-4-iodo-1H-pyrazole-5-carboxylic acid | C8H11IN2O2 | 1354705-19-3 | Details |
2-(1-Cyclopropyl-1H-1,2,3,4-tetrazol-5-yl)aniline | C10H11N5 | 1000932-36-4 | Details |
A2M antibody | Details |
Volagidemab | 1233956-13-2 | Details |
Ethyl propiolate | C5H6O2 | 623-47-2 | Details |
2-amino-1-(2-bromophenyl)ethan-1-ol | C8H10BrNO | 71095-20-0 | Details |
3,3-difluorocyclopentanol | C5H8F2O | 883731-65-5 | Details |
2-Bromo-5-tert-butylphenol | C10H13BrO | 20942-68-1 | Details |
H-His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 | C46H56N12O6 | 87616-84-0 | Details |
Ginsenoside Rh3 | C36H60O7 | 105558-26-7 | Details |
Tb-epsilon Heavy | Details |
H-DSLYLQMNSLR-OH | Details |
2-(2-Chloro-6-fluorophenyl)morpholine | C10H11ClFNO | 1017480-74-8 | Details |
tert-Butyl 3-[2-(benzyloxy)-2-oxoethylidene]azetidine-1-carboxylate | C17H21NO4 | 1803588-48-8 | Details |
N-(2,3-dimethyl-5-oxo-1-phenyl(3-pyrazolin-4-yl))((4-(trifluoromethoxy)phenyl)amino)formamide | C19H17F3N4O3 | 946386-37-4 | Details |
2-(Trifluoromethyl)-2H-chromene-3-carboxylic acid | C11H7F3O3 | 215122-16-0 | Details |
PENK Blocking Peptide | Details |
6-amino-N-methylpyridine-3-carboxamide | C7H9N3O | 94924-86-4 | Details |
2-Chloro-4-fluoro-1-isocyanatobenzene | C7H3ClFNO | 1016788-39-8 | Details |
7-Imino-2-phenylthieno(3,2-C)pyridine-4,6(5H,7H)-dione | C13H8N2O2S | 1954650-11-3 | Details |
2-{4H,5H,6H,7H-Pyrazolo[1,5-a]pyridin-3-yl}ethan-1-amine | C9H15N3 | 1556315-40-2 | Details |
anti-Mouse IgG1 Antibody (Goat) - Affinity Purified | Details |
2-(4-Cyclopropylphenyl)ethan-1-amine hydrochloride | C11H16ClN | 1439903-99-7 | Details |
H-GTDVQAWIR-OH | Details |
2-[4-(But-3-en-2-yloxy)-3,5-dimethoxyphenyl]ethan-1-amine | 1458373-35-7 | Details |
6-Amino-9-methyl-2-thia-9-azatricyclo[9.4.0.0,3,8]pentadeca-1(15),3,5,7,11,13-hexaen-10-one | C14H12N2OS | 950858-26-1 | Details |
Olokizumab | 1007223-17-7 | Details |
YH-1238 | 195889-55-5 | Details |
H-VSKTETSQVAPA-OH | Details |
SLC17A4 Blocking Peptide | Details |
tert-Butyl 4-amino-3,4-dihydrospiro[1-benzopyran-2,3'-pyrrolidine]-1'-carboxylate | C17H24N2O3 | 2137917-15-6 | Details |
{5-Oxaspiro[3.4]octan-6-yl}methanesulfonyl chloride | C8H13ClO3S | 2137854-82-9 | Details |
Amyloid beta-Protein (1-40) (mouse, rat) | C190H291N51O57S | 144409-98-3 | Details |
2',5'-Dideoxyguanosine | C10H13N5O3 | 136884-63-4 | Details |
2'H-Dispiro[1,3-dioxolane-2,1'-indene-3',2'-[1,3]dioxolane]-7'-amine | C13H15NO4 | 54304-75-5 | Details |
4-Hydroxy-3-[(morpholin-4-yl)methyl]benzaldehyde hydrochloride | C12H16ClNO3 | 1135221-62-3 | Details |
COPB1 Blocking Peptide | Details |
2,2,3,3-Tetrafluoropropan-1-amine hydrochloride | C3H6ClF4N | 663-65-0 | Details |
2-[(1S,3S)-3-Aminocyclobutyl]acetonitrile hydrochloride | C6H11ClN2 | 2361645-64-7 | Details |
3-(1-Amino-2-phenylethyl)-4,5-dihydro-1H-1,2,4-triazol-5-one hydrochloride | C10H13ClN4O | 1674389-85-5 | Details |
Hexokinase Type 1 antibody | Details |
Topoisomerase II antibody | Details |
3-[4-(Propan-2-yl)phenyl]azetidin-3-ol hydrochloride | C12H17NO.ClH | 2375273-17-7 | Details |
1-(4-Chlorophenyl)-2-methoxyethan-1-one | C9H9ClO2 | 30780-45-1 | Details |
Product Total: Product Page: | ||||
833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 |